Advertisement
Screener

SkinHealth Systems Inc. (SKIN) Graph

SKIN Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $72.11M; Cost of revenue $22.77M; Research and development $1.41M; Operating expenses $45.77M.
  • 2026-03-31: Revenue $64.91M; Cost of revenue $20.47M; Research and development $1.10M; Operating expenses $46.24M.
  • 2025-12-31: Revenue $82.37M*; Cost of revenue $29.33M*; Research and development $1.68M*; Operating expenses $52.88M*.
  • 2025-09-30: Revenue $70.66M; Cost of revenue $25.02M; Research and development $1.70M; Operating expenses $51.88M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

SKIN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Consumables$53.86MDelivery Systems$18.25MRevenue$72.11MCost of revenue$22.78MGross profit$49.34MOperating expenses$45.77MOperating income$3.57MOther income, net$19.00KResearch & development$1.41MPre-tax income-$1.46MNet income-$2.67M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

SKIN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Americas$49.89MAsia Pacific$7.30MEMEA$14.92MRevenue$72.11MCost of revenue$22.78MGross profit$49.34MOperating expenses$45.77MOperating income$3.57MOther income, net$19.00KResearch & development$1.41MPre-tax income-$1.46MNet income-$2.67M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$72.11M$22.77M$1.41M$45.77M$1.21M-$2.67M
2026-03-31$64.91M$20.47M$1.10M$46.24M-$184.00K-$6.63M
2025-12-31$82.37M*$29.33M*$1.68M*$52.88M*$3.30M*-$8.09M*
2025-09-30$70.66M$25.02M$1.70M$51.88M$386.00K-$11.03M
2025-06-30$78.19M$29.07M$1.25M$51.81M-$993.00K$19.71M
2025-03-31$69.58M$21.00M$998.00K$60.60M$892.00K-$10.10M
2024-09-30$78.80M$38.15M$1.11M$62.16M$1.95M-$18.29M
2024-06-30$90.59M$49.65M$1.16M$63.05M-$353.00K$202.00K
2024-03-31$81.40M$33.04M$2.81M$65.35M-$659.00K-$679.00K
2023-09-30$97.41M$109.97M$1.84M$69.55M$3.48M-$73.82M
2023-06-30$117.48M$49.60M$2.88M$81.02M-$2.19M$3.36M
2023-03-31$86.28M$32.17M$2.34M$71.41M-$3.66M-$20.26M
2022-09-30$88.79M$27.43M$2.17M$65.72M-$821.00K-$81.00K
2022-06-30$103.54M$33.50M$2.60M$75.07M$76.00K$6.32M
2022-03-31$75.42M$24.53M$2.23M$64.90M$2.62M$31.45M
2021-09-30$68.15M$22.07M$1.88M$51.53M-$1.13M-$215.15M
2021-06-30$66.51M$19.26M$2.99M$73.60M-$1.87M-$139.38M
2021-03-31$47.54M$15.80M$1.45M$29.36M-$306.00K-$3.27M
2020-09-30$34.56M$13.60M$577.00K$18.17M-$593.00K-$2.21M
2020-06-30$14.12M$9.84M$597.00K$12.20M-$3.05M-$10.40M
2020-03-31(m)(m)(m)(m)(m)-$9.07M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$137.02M$43.25M$2.51M$92.01M$1.02M-$9.30M
2025-06-30$147.77M$50.08M$2.25M$112.42M-$101.00K$9.62M
2024-06-30$172.00M$82.70M$3.97M$128.40M-$1.01M-$477.00K
2023-06-30$203.76M$81.78M$5.22M$152.44M-$5.86M-$16.89M
2022-06-30$178.95M$58.03M$4.83M$139.97M$2.69M$37.77M
2021-06-30$114.05M$35.06M$4.44M$102.96M-$2.18M-$142.65M
2020-12-31(m)(m)(m)(m)(m)-$81.62M
2020-06-30$46.65M$23.45M$1.97M$38.46M-$5.67M-$19.47M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$218.42M$75.10M$3.95M$164.29M$285.00K-$1.42M
2024-09-30$250.80M$120.85M$5.07M$190.57M$936.00K-$18.77M
2023-09-30$301.17M$191.74M$7.06M$221.98M-$2.38M-$90.71M
2022-09-30$267.74M$85.45M$7.00M$205.68M$1.87M$37.69M
2021-09-30$182.20M$57.13M$6.32M$154.49M-$3.31M-$357.80M
2020-09-30$81.21M$37.05M$2.55M$56.63M-$6.26M-$21.68M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$300.79M$104.43M$5.63M$217.17M$3.58M-$9.50M
2024-12-31$334.29M$152.00M$6.30M$250.07M-$452.00K-$29.10M
2023-12-31$397.99M$242.88M$10.10M$286.03M-$1.77M-$100.10M
2022-12-31$365.88M$117.10M$8.44M$274.62M$1.11M$44.20M
2021-12-31$260.09M$81.55M$8.20M$218.47M-$1.88M$378.70M
2020-12-31$119.09M$51.89M$3.41M$84.38M-$9.31M-$29.18M
2019-12-31$166.62M$60.11M$4.61M$93.05M-$1.30M-$1.64M

Similar stocks

Stock NameCountryMarket CapPE Ratio
LENSAR, Inc. (LNSR)United States$0.087B2.02
Microbot Medical Inc. (MBOT)$0.089B-7.97
Pulmonx Corp (LUNG)United States$0.082B-1.16
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Apyx Medical Corp (APYX)United States$0.120B-21.85